GELSOMINO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 946
EU - Europa 898
AS - Asia 84
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 3
Totale 1962
Nazione #
US - Stati Uniti d'America 919
UA - Ucraina 295
AT - Austria 215
DE - Germania 141
SE - Svezia 123
IT - Italia 82
CN - Cina 40
TR - Turchia 28
CA - Canada 26
SN - Senegal 21
BE - Belgio 13
GB - Regno Unito 8
IN - India 8
FR - Francia 6
AU - Australia 5
EU - Europa 5
NL - Olanda 5
BR - Brasile 3
FI - Finlandia 3
RU - Federazione Russa 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CH - Svizzera 1
ES - Italia 1
IL - Israele 1
IM - Isola di Man 1
JP - Giappone 1
LK - Sri Lanka 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
Totale 1962
Città #
Chandler 327
Vienna 162
Jacksonville 138
San Mateo 130
Dearborn 55
Lawrence 44
Roxbury 44
Bremen 28
Des Moines 25
Inglewood 23
Izmir 23
Ann Arbor 22
Dakar 21
Brooklyn 19
Wilmington 19
Ottawa 18
Rende 18
Redwood City 16
Brussels 13
Beijing 12
Cosenza 7
Grafing 6
Toronto 6
Cambridge 5
San Francisco 5
Zhengzhou 5
Augusta 4
Hanover 4
Hefei 4
Kocaeli 4
Nanjing 4
Ningbo 4
Palermo 4
Canberra 3
Cassano Allo Ionio 3
Elk Grove Village 3
Fort Collins 3
Helsinki 3
Jinan 3
Monmouth Junction 3
Naaldwijk 3
San Giuliano Milanese 3
The Dalles 3
Amsterdam 2
Ashburn 2
Boardman 2
Casal Di Principe 2
Chicago 2
Civitavecchia 2
Curtarolo 2
Falls Church 2
Guangzhou 2
Houston 2
Leawood 2
Noicattaro 2
Reggio Calabria 2
Riyadh 2
Bear 1
Borås 1
Buffalo 1
Chengdu 1
Chieri 1
Colombo 1
Douglas 1
Falkenstein 1
Frankfurt am Main 1
Grottaglie 1
Hebei 1
Islamabad 1
Kunming 1
Lisbon 1
Lodi 1
London 1
Madrid 1
Manila 1
Marsala 1
Mascalucia 1
Melbourne 1
Mumbai 1
Nagold 1
Nanchang 1
Naples 1
New Delhi 1
Norwalk 1
Palizzi Marina 1
Rome 1
Shanghai 1
Sofia 1
Sydney 1
Tel Aviv 1
Trebaseleghe 1
Viareggio 1
Zurich 1
Totale 1313
Nome #
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 75
The emerging role of adiponectin in female malignancies 68
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network 63
Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression 63
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 62
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 62
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 62
Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness 61
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 58
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression 58
Oldenlandia Diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation 57
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 57
May tumor microenvironment cooperate with a mutant ERalpha to promote breast cancer progression? 55
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 54
Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth 53
null 51
The Role of PPARγ Ligands in Breast Cancer: from Basic Research to Clinical Studies 50
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication 48
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer 47
Development of a Leptin Antagonist Peptide: Implications for Breast Cancer 46
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 46
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling 43
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 43
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 43
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 42
Interfering Role of ERα on Adiponectin Action in Breast Cancer 41
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth. 40
Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells 39
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells 38
FXR ligands, by interfering with tumor/microenvironment crosstalk, inhibit breast tumor growth and progression. 37
null 37
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 37
Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression 37
Targeting thyroid hormone receptor beta in triple-negative breast cancer 36
Natural and synthetic PPARγ ligands in tumor microenvironment: a new potential strategy against breast cancer 36
The biology of exosomes in breast cancer progression: Dissemination, immune evasion and metastatic colonization 34
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 34
Obesity, leptin and breast cancer: Epidemiological evidence and proposed mechanisms 34
Tumor microenviroment cooperate with a mutant ERalpha to promote breast cancer progression? 33
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo 31
May tumor microenvironment cooperate with a mutant ERα to promote breast cancer progression? 29
The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer 26
Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell Lines 25
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 23
Hormonal modulation of ESR1 mutant metastasis 22
Uncoupling effects of ERalpha on LKB1/AMPK signaling induced by adiponectin in breast cancer cells 8
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives 8
null 7
Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism 1
Totale 2060
Categoria #
all - tutte 6990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201836 0000 00 032 1003
2018/201967 0054 200 20 48231
2019/2020324 2726426 1560 3048 9144025
2020/2021337 3834442 238 1846 26441323
2021/2022634 6107679 5710 1145 9371140
2022/2023656 9313148116 12186 601 0000
Totale 2060